Trends in High-Intensity Statin Therapy After Myocardial Infarction Among U.S. Adults, 2011-2019-Reference-Cited by-同舟云学术

Trends in High-Intensity Statin Therapy After Myocardial Infarction Among U.S. Adults, 2011-2019

Published:2022-05 Issue:18 Volume:79 Page:1870-1872
ISSN:0735-1097
Container-title:Journal of the American College of Cardiology
language:en
Short-container-title:Journal of the American College of Cardiology

Author:

Colantonio Lisandro D.,Wang Zhixin,Chen Ligong,Mejia Raul,Bittner Vera,Muntner Paul,Rosenson Robert S.

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference5 articles.

1. 2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA guideline on the management of blood cholesterol: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines;Grundy;J Am Coll Cardiol,2019

2. Trends in use of high-intensity statin therapy after myocardial infarction, 2011 to 2014;Rosenson;J Am Coll Cardiol,2017

3. Ischemic event rates in very-high-risk adults;Colantonio;J Am Coll Cardiol,2019

4. Statin prescription for patients with atherosclerotic cardiovascular disease from national survey data;Vatcheva;Am J Cardiol,2019

5. Race-sex differences in statin use and low-density lipoprotein cholesterol control among people with diabetes mellitus in the reasons for geographic and racial differences in stroke study;Gamboa;J Am Heart Assoc,2017

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cardiac adverse events associated with statins in myocardial infarction patients: a pharmacovigilance analysis of the FDA Adverse Event Reporting System;2024-08-16

2. Trend of Controlled Low-Density Lipoprotein Cholesterol in Older Adults With a History of Myocardial Infarction or Stroke;JACC: Advances;2024-08

3. Low-Density Lipoprotein Cholesterol Testing Following Myocardial Infarction Hospitalization Among Medicare Beneficiaries;JACC: Advances;2024-01

4. Recurrent Atherosclerotic Cardiovascular Disease Events Potentially Prevented with Guideline-Recommended Cholesterol-Lowering Therapy following Myocardial Infarction;Cardiovascular Drugs and Therapy;2023-04-13

5. Missed opportunities in secondary prevention with statins;Heart;2022-11-04